| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 18 member A2 | 0.554 | 0.769 | 7.6E-02 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1995 | 2018 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1995 | 2019 | ||||||||
|
FMRP translational regulator 1 | 0.473 | 0.769 | 0.65 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2016 | ||||||||
|
glutamate ionotropic receptor AMPA type subunit 2 | 0.573 | 0.692 | 1.00 |
|
disease | 0.360 | None | 0.500 | 2 | 0 | 1995 | 2020 | ||||||||
|
glutamate ionotropic receptor AMPA type subunit 1 | 0.570 | 0.577 | 1.00 |
|
disease | 0.500 | None | 1.000 | 2 | 2 | 1995 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.600 | None | 0.780 | 1 | 0 | 1995 | 2019 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.964 | 1 | 2 | 1995 | 2019 | ||||||||
|
synaptophysin | 0.481 | 0.808 | 0.92 |
|
disease | 0.370 | None | 0.875 | 1 | 0 | 1995 | 2019 | ||||||||
|
glutamate metabotropic receptor 2 | 0.582 | 0.577 | 0.12 |
|
disease | 0.400 | None | 0.893 | 1 | 0 | 1995 | 2019 | ||||||||
|
dopamine receptor D1 | 0.529 | 0.808 | 0.96 |
|
disease | 0.400 | None | 0.964 | 1 | 0 | 1995 | 2017 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1996 | 2019 | ||||||||
|
ciliary neurotrophic factor | 0.561 | 0.615 | 2.3E-05 |
|
disease | 0.390 | None | 0.250 | 4 | 0 | 1996 | 2008 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
disease | 0.370 | None | 0.750 | 4 | 0 | 1996 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1F | 0.716 | 0.192 | 4.7E-03 |
|
disease | 0.370 | None | 0.500 | 2 | 0 | 1996 | 2004 | ||||||||
|
monoamine oxidase A | 0.465 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 1 | 7 | 1996 | 2017 | ||||||||
|
glutamate ionotropic receptor kainate type subunit 2 | 0.561 | 0.769 | 1.00 |
|
disease | 0.350 | None | 0.667 | 1 | 0 | 1996 | 2017 | ||||||||
|
monoamine oxidase B | 0.533 | 0.808 | 1.00 |
|
disease | 0.400 | None | 0.889 | 1 | 0 | 1996 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
disease | 0.370 | None | 0.500 | 1 | 0 | 1996 | 2017 | ||||||||
|
T-box transcription factor 1 | 0.433 | 0.808 | 0.84 |
|
disease | 0.500 | None | 1.000 | 5 | 1 | 1997 | 2017 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.859 | 3 | 1 | 1997 | 2019 | ||||||||
|
phospholipase A2 group IB | 0.468 | 0.846 | 1.0E-10 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1997 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1997 | 2019 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
disease | 0.500 | None | 1.000 | 3 | 1 | 1997 | 2019 |